BPG is committed to discovery and dissemination of knowledge
-
|
Homepage
|
-
|
Online Submission
|
- Number of total visits
-
30632186
- Number of visits today
- 2035
- Number of downloads
-
13060174
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Curtin N, Bai P. PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer. Cancers (Basel) 2020;12:E3494. [PMID: 33255262 DOI: 10.3390/cancers12123494] [Reference Citation Analysis]
|
2 |
Maluchenko NV, Feofanov AV, Studitsky VM. PARP-1-Associated Pathological Processes: Inhibition by Natural Polyphenols. Int J Mol Sci 2021;22:11441. [PMID: 34768872 DOI: 10.3390/ijms222111441] [Reference Citation Analysis]
|
3 |
Neitzel C, Demuth P, Wittmann S, Fahrer J. Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities. Cancers (Basel) 2020;12:E1731. [PMID: 32610612 DOI: 10.3390/cancers12071731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
4 |
Pandey N, Black BE. Rapid Detection and Signaling of DNA Damage by PARP-1. Trends Biochem Sci 2021;46:744-57. [PMID: 33674152 DOI: 10.1016/j.tibs.2021.01.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
|
5 |
Zhou Y, Liu L, Tao S, Yao Y, Wang Y, Wei Q, Shao A, Deng Y. Parthanatos and its associated components: Promising therapeutic targets for cancer. Pharmacol Res 2021;163:105299. [PMID: 33171306 DOI: 10.1016/j.phrs.2020.105299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
6 |
Saitoh T, Oda T. DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment. Cancers (Basel) 2021;13:504. [PMID: 33525741 DOI: 10.3390/cancers13030504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345